Literature DB >> 17582678

High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.

Cristina Martínez-Bouzas1, Enrique Ojembarrena, Elena Beristain, Javier Errasti, Noelia Viguera, Maria-Isabel Tejada Minguéz.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC), which represents the most common form of inherited colorectal cancer, results from germline alterations of the mismatch repair genes MSH2, MLH1 and MSH6. Rearrangements of MSH2 and MLH1 are involved in at least 10% and 4.3%, respectively, of the HNPCC families fulfilling the Amsterdam (AMS) criteria. We applied a recently developed method, multiplex ligation-dependent probe amplification (MLPA), to study MLH1/MSH2 copy number changes in 29 unrelated Basque Country HNPCC families. We detected six different genomic rearrangements in total (6/29=20.69%), four in MSH2 gene (13.79%), and two in MLH1 gene. All of the MSH2 rearrangements were genomic deletions involving several exons. The MLH1 rearrangements were initially detected as one deletion of exon 18 and one deletion of exon 19, but after sequencing analysis, these deletions were not confirmed and corresponded to base pair mutations. We conclude that MLPA is an excellent tool for detecting exon copy number changes in MLH1 and MSH2 in the DNA from HNPCC patients, although all detected rearrangements should be confirmed by an independent molecular methodology. Furthermore, our results in the Basque Country show higher percentages of rearrangements than previously published by other authors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582678     DOI: 10.1016/j.canlet.2007.05.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Expanding clinical phenotype in CACNA1C related disorders: From neonatal onset severe epileptic encephalopathy to late-onset epilepsy.

Authors:  Xiuhua Bozarth; Jennifer N Dines; Qian Cong; Ghayda M Mirzaa; Kimberly Foss; J Lawrence Merritt; Jenny Thies; Heather C Mefford; Edward Novotny
Journal:  Am J Med Genet A       Date:  2018-12-04       Impact factor: 2.802

2.  Missense mutations in MLH1, MSH2, KRAS, and APC genes in colorectal cancer patients in Malaysia.

Authors:  Nor Azian Abdul Murad; Zulhabri Othman; Melati Khalid; Zuraini Abdul Razak; Rosniza Hussain; Sukumar Nadesan; Ismail Sagap; Isa Mohamed Rose; Wan Zurinah Wan Ngah; Rahman Jamal
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

3.  First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.

Authors:  H Ziada-Bouchaar; K Sifi; T Filali; T Hammada; D Satta; N Abadi
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

4.  A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations.

Authors:  Cristina Martínez-Bouzas; Elena Beristain; Enrique Ojembarrena; Jose Errasti; Karmele Mujika; Noelia Viguera; Maria Isabel Tejada
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

5.  Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

Authors:  Georgia Thodi; Florentia Fostira; Raphael Sandaltzopoulos; George Nasioulas; Anastasios Grivas; Ioannis Boukovinas; Maria Mylonaki; Christos Panopoulos; Mirjana Brankovic Magic; George Fountzilas; Drakoulis Yannoukakos
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

6.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

7.  Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome.

Authors:  Lin Dong; Shuangmei Zou; Xianglan Jin; Haizhen Lu; Ye Zhang; Lei Guo; Jianqiang Cai; Jianming Ying
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

8.  Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.

Authors:  Francesca Duraturo; Angela Cavallo; Raffaella Liccardo; Bianca Cudia; Marina De Rosa; Giuseppe Diana; Paola Izzo
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

9.  Frequency and variability of genomic rearrangements on MSH2 in Spanish Lynch Syndrome families.

Authors:  Atocha Romero; Pilar Garre; Olivia Valentin; Julian Sanz; Pedro Pérez-Segura; Patricia Llovet; Eduardo Díaz-Rubio; Miguel de la Hoya; Trinidad Caldés
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

10.  Report of a germline double heterozygote in MSH2 and PALB2.

Authors:  Konstantinos Agiannitopoulos; Eirini Papadopoulou; Georgios N Tsaousis; Georgia Pepe; Stavroula Kampouri; Eleni Patsea; George Lypas; George Nasioulas
Journal:  Mol Genet Genomic Med       Date:  2020-08-27       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.